Study of IL-35 levels in Multiple Myeloma patients and its Relation with Immunoglobulins
Abstract
Multiple myeloma (MM) is a malignant disorder characterized by the proliferation of plasma cellsand the second most common hematological standing next to lymphoma. Multiple myeloma patients commonly present with defects in numbers and function of various immune cells including dendritic cells ,B cells,Tcells and natural kill cells[23].Interleukin- 35 (IL-35) is a novel anti-inflammatory cytokine suppressing the immune response through the expansion of regulatory T cells and suppression of Th17 cell development.The present study aimedto investigate the possible role of IL-35 in pathogenesis of MM and its relation withimmunoglobulins such as IgA,IgG and IgM.Forty Iraqis patients with multiple myeloma(G1,G2) and twenty healthy individuals as a control group (G1)were enrolled in this study.Whole blood used for determination of hemoglobin. Serum samples were used for determination of albumin,total protein using standard procedures of the biochemistry laboratory of hospital. Also immunoglobulin's (IgA,IgG,IgM) and IL-35 were determined in serum.The results revealed a significant increasing in urine total protein ,ESR,creatinine ,uric acid ,BUN, and TP in patients groups(G2,G3) comparing to control group(G1) while a significant decrease in albumin and Hb were found in patients groups comparing to control .Also a significant differences was observed in calcium concentration in G3 compared to G2 while there are no differences was observed between G2 and G1 . The results shown highly significant increase in IgA,IgG, IgM and IL-35,in patients groups comparing to control group. Also a significant differences were noticed in G3 comparing to G2. A highly significant positive correlation between IL-35 and IgA was noted in G2 and G3. Also a highly significant positive correlation between IL-35 and IgG levels was noticed in G2 and G3. Moreover a significant negative correlation founded between IL-35 andIgM in G2 and G3 .A conclusion could be drown from this study for the first time that MM patients showed increasing in IL-35 levels so, it may be considered as a novel cytokine involved in the pathogenesis of MM.
Keyword:IL-35,Multiple Myeloma,Immunoglobulines.
To list your conference here. Please contact the administrator of this platform.
Paper submission email: JNSR@iiste.org
ISSN (Paper)2224-3186 ISSN (Online)2225-0921
Please add our address "contact@iiste.org" into your email contact list.
This journal follows ISO 9001 management standard and licensed under a Creative Commons Attribution 3.0 License.
Copyright © www.iiste.org